Bio-X
Showing 621-640 of 1,076 Results
-
Ravi Majeti MD, PhD
Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Virginia and D. K. Ludwig Professor and Professor of Medicine (Hematology/Stem Cell Institute)
Current Research and Scholarly InterestsThe Majeti lab focuses on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly acute myeloid leukemia (AML). Our lab uses experimental hematology methods, stem cell assays, genome editing, and bioinformatics to define and investigate drivers of leukemia stem cell behavior. As part of these studies, we have led the development and application of robust xenotransplantation assays for human hematopoietic cells.
-
Joshua Makower
Yock Family Professor and Professor of Bioengineering
Current Research and Scholarly InterestsDr. Josh Makower is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering and the Director of the Stanford Byers Center for Biodesign, the program he co-founded with Dr. Paul Yock twenty years ago. Josh helped create the fundamental structure of the Center’s core curriculum and is the chief architect of what is now called “The Biodesign Process.” Over the past 20 years since Josh and Paul founded Biodesign, this curriculum and the associated textbook has been used at Stanford and across the world to train hundreds of thousands of students, faculty and industry leaders on the Biodesign process towards the advancement of medical innovation for the improvement of patient care. Josh has practiced these same techniques directly as the Founder & Executive Chairman of ExploraMed, a medical device incubator, creating 9 companies since 1995. Transactions from the ExploraMed portfolio include NeoTract, acquired by Teleflex, Acclarent, acquired by J&J, EndoMatrix, acquired by C.R. Bard & TransVascular, acquired by Medtronic. Other ExploraMed/NEA ventures include Moximed, NC8 and Willow. Josh is also a Special Partner at NEA where he supports the healthcare team and medtech/healthtech investing practice. Josh serves on the boards of Allay Therapeutics, Revelle Aesthetics, Setpoint Medical, DOTS Technologies, Eargo, ExploraMed, Intrinsic Therapeutics, Moximed, Willow and Coravin. Josh holds over 300 patents and patent applications. He received an MBA from Columbia University, an MD from the NYU School of Medicine, a bachelor’s degree in Mechanical Engineering from MIT. Josh is a Member of the National Academy of Engineering and the College of Fellows of The American Institute for Medical and Biological Engineering and was awarded the Coulter Award for Healthcare Innovation by the Biomedical Engineering Society in 2018.
-
Yvonne Maldonado
Senior Associate Dean, Faculty Development and Diversity, Taube Professor of Global Health and Infectious Diseases, Professor of Pediatrics (Infectious Diseases) and of Epidemiology and Population Health
On Partial Leave from 01/01/2025 To 08/31/2025Current Research and Scholarly InterestsMy research focuses on epidemiologic aspects of viral vaccines and perinatal HIV infection. This includes the molecular epidemiology of factors affecting the immunogenicity of oral polio vaccine (OPV) in developing areas of the world, and now the epidemiology of transmission and circulation of vaccine derived polioviruses in order to assist in global eradication of polio. I also work in development of methods to prevent breastfeeding transmission of HIV in Africa.
-
Robert Malenka
Nancy Friend Pritzker Professor of Psychiatry and Behavioral Sciences
On Leave from 11/01/2023 To 10/31/2025Current Research and Scholarly InterestsLong-lasting changes in synaptic strength are important for the modification of neural circuits by experience. A major goal of my laboratory is to elucidate the molecular events that trigger various forms of synaptic plasticity and the modifications in synaptic proteins that are responsible for the changes in synaptic efficacy.
-
Parag Mallick
Associate Professor (Research) of Radiology (Diagnostic Sciences Laboratory)
Current Research and Scholarly InterestsThe Mallick Lab is focused on using integrative, multi-omic approaches to model the processes that govern cellular dynamics and to use those models to discover cancer biomarkers and molecular mechanisms.
-
Edward Manche, MD
Professor of Ophthalmology
BioEdward E. Manche, MD is Professor of Ophthalmology and Director of the Cornea and Refractive Surgery Service at Stanford University School of Medicine. He received his medical degree from Albert Einstein College of Medicine and completed residency training at the University of Medicine and Dentistry at New Jersey where he served as Chief Resident. He completed a two-year fellowship in Cornea and Refractive Surgery at the Jules Stein Eye Institute at UCLA.
Dr. Manche is a fellow of the American Academy of Ophthalmology and received its Achievement Award in 2003 and its Senior Achievement Award in 2014. He was elected to active membership in the American Ophthalmological Society in 2011, and is recognized in Best Doctors in America and Guide to America's Top Physicians. He serves on the editorial boards of the American Journal of Ophthalmology, Journal of Ophthalmology, Clinical and Experimental Ophthalmology and Journal of Refractive Surgery.
He lectures widely on topics in cornea and refractive surgery and has published over 130 peer-reviewed articles and 30 book chapters. -
Christopher Manning
Thomas M. Siebel Professor of Machine Learning, Professor of Linguistics, of Computer Science and Senior Fellow at the Stanford Institute for HAI
BioChristopher Manning is the inaugural Thomas M. Siebel Professor in Machine Learning in the Departments of Linguistics and Computer Science at Stanford University, Director of the Stanford Artificial Intelligence Laboratory (SAIL), and an Associate Director of the Stanford Institute for Human-Centered Artificial Intelligence (HAI). From 2010, Manning pioneered Natural Language Understanding and Inference using Deep Learning, with impactful research on sentiment analysis, paraphrase detection, the GloVe model of word vectors, attention, neural machine translation, question answering, self-supervised model pre-training, tree-recursive neural networks, machine reasoning, dependency parsing, and summarization, work for which he has received two ACL Test of Time Awards and the IEEE John von Neumann Medal (2024). He earlier led the development of empirical, probabilistic approaches to NLP, computational linguistics, and language understanding, defining and building theories and systems for Natural Language Inference, syntactic parsing, machine translation, and multilingual language processing, work for which he won ACL, Coling, EMNLP, and CHI Best Paper Awards. In NLP education, Manning coauthored foundational textbooks on statistical approaches to NLP (Manning and Schütze 1999) and information retrieval (Manning, Raghavan, and Schütze, 2008), and his online CS224N Natural Language Processing with Deep Learning course videos have been watched by hundreds of thousands. In linguistics, Manning is a principal developer of Stanford Dependencies and Universal Dependencies, and has authored monographs on ergativity and complex predicates. He is the founder of the Stanford NLP group (@stanfordnlp) and was an early proponent of open source software in NLP with Stanford CoreNLP and Stanza. He is an ACM Fellow, a AAAI Fellow, and an ACL Fellow, and a Past President of the ACL (2015). Manning has a B.A. (Hons) from The Australian National University, a Ph.D. from Stanford in 1994, and an Honorary Doctorate from U. Amsterdam in 2023. He held faculty positions at Carnegie Mellon University and the University of Sydney before returning to Stanford.
-
Andrew J. Mannix
Assistant Professor of Materials Science and Engineering
Current Research and Scholarly InterestsAtomically thin 2D materials incorporated into van der Waals heterostructures are a promising platform to deterministically engineer quantum materials with atomically resolved thickness and abrupt interfaces across macroscopic length scales while retaining excellent material properties. Because 2D materials exhibit a wide range of electronic characteristics with properties that often rival conventional electronic materials — e.g., metals, semiconductors, insulators, and superconductors — it is possible to combine them in virtually infinite variety to achieve diverse heterostructures. Furthermore, the van der Waals interface enables interlayer twist engineering to modify the interlayer symmetry, periodic potential (moiré superlattice), and hybridization, which has resulted in novel quantum states of matter. Many of these heterostructures, especially those involving specific interlayer twist angles, would be otherwise infeasible through direct growth.
The Mannix Group is developing a unique set of in-house capabilities to systematically elucidate the fundamental structure-property relationships underpinning the growth of 2D materials and their inclusion into van der Waals heterostructures. Greater understanding will allow us to provide a platform for engineering the properties of matter at the atomic scale and offer guidance for emerging applications in novel electronics and in quantum information science.
To accomplish this, we employ: precise growth techniques such as chemical vapor deposition and molecular beam epitaxy; automated van der Waals assembly; and atomically-resolved microscopy including cryo-STM/AFM. -
Ivana Maric
Assistant Professor (Research) of Pediatrics (Neonatology)
BioIvana Maric is an Assistant Professor in the Pediatrics Department at the Stanford University School of Medicine. Her research focuses on applying machine learning to improving maternal and neonatal health. Her main focus has been on developing machine learning models for early prediction of adverse outcomes of pregnancy from omics and electronic health records data, that could guide development of low-cost, point of care diagnostic tools. Her main interest is in solutions that are applicable worldwide and especially in low-resource settings. Previously, her research focused on information theory, a mathematical discipline tightly related to statistics and machine learning. She is a recipient of the 2021 Rosenkranz Prize awarded for innovative work to improve health in low- or middle-income countries. She is also a co-recipient of the 2013 IEEE Communications Society Best Tutorial Paper Award.
She received BS degree from the University of Novi Sad, Serbia, MS and PhD at Rutgers University and postdoctoral training at Stanford University. She served as an Associate Editor for the IEEE Communications Letters from 2009 to 2012 and for the Trans. on Emerging Telecommunications Technologies from 2016 to 2018. -
M. Peter Marinkovich, MD
Associate Professor of Dermatology
Current Research and Scholarly InterestsThe Marinkovich lab studies the function of epithelial extracellular matrix molecules, including integrins, collagens and laminins in epithelial development and carcinoma progression. We apply our discoveries in this area towards development of molecular therapies for carcinomas, hair disease and inherited epithelial adhesive disorders.
-
Thomas E. Markland
Associate Professor of Chemistry
Current Research and Scholarly InterestsOur research centers on problems at the interface of quantum and statistical mechanics. Particular themes that occur frequently in our research are hydrogen bonding, the interplay between structure and dynamics, systems with multiple time and length-scales and quantum mechanical effects. The applications of our methods are diverse, ranging from chemistry to biology to geology and materials science. Particular current interests include proton and electron transfer in fuel cells and enzymatic systems, atmospheric isotope separation and the control of catalytic chemical reactivity using electric fields.
Treatment of these problems requires a range of analytic techniques as well as molecular mechanics and ab initio simulations. We are particularly interested in developing and applying methods based on the path integral formulation of quantum mechanics to include quantum fluctuations such as zero-point energy and tunneling in the dynamics of liquids and glasses. This formalism, in which a quantum mechanical particle is mapped onto a classical "ring polymer," provides an accurate and physically insightful way to calculate reaction rates, diffusion coefficients and spectra in systems containing light atoms. Our work has already provided intriguing insights in systems ranging from diffusion controlled reactions in liquids to the quantum liquid-glass transition as well as introducing methods to perform path integral calculations at near classical computational cost, expanding our ability to treat large-scale condensed phase systems. -
Ellen Markman
IBM Provostial Professor
BioMarkman’s research interests include the relationship between language and thought; early word learning; categorization and induction; theory of mind and pragmatics; implicit theories and conceptual change, and how theory-based explanations can be effective interventions in health domains.
-
Michael Marmor, MD
Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsResearch concerns diseases of retinal function, techniques of clinical electrophysiology, and experimental studies on retinal pigment epithelial (RPE) function including fluid transport and retinal adhesiveness. Other studies consider aspects of vision and art, and ophthalmic history.
Published over 300 journal articles, chapters, books (only selected articles listed). -
David J. Maron
C. F. Rehnborg Professor and Professor of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsDr. Maron is the Co-Chair and Principal Investigator of the ISCHEMIA trial, and Co-Chair of the ISCHEMIA-CKD trial. These large, international, NIH-funded studies will determine whether an initial invasive strategy of cardiac catheterization and revascularization plus optimal medical therapy will reduce cardiovascular events in patients with and without chronic kidney disease and at least moderate ischemia compared to an initial conservative strategy of optimal medical therapy alone.
-
Alison Marsden
Douglass M. and Nola Leishman Professor of Cardiovascular Diseases, Professor of Pediatrics (Cardiology) and of Bioengineering and, by courtesy, of Mechanical Engineering
Current Research and Scholarly InterestsThe Cardiovascular Biomechanics Computation Lab at Stanford develops novel computational methods for the study of cardiovascular disease progression, surgical methods, and medical devices. We have a particular interest in pediatric cardiology, and use virtual surgery to design novel surgical concepts for children born with heart defects.
-
Nicole M. Martinez
Assistant Professor of Chemical and Systems Biology and of Developmental Biology
Current Research and Scholarly InterestsThe Martinez lab studies RNA regulatory mechanisms that control gene expression. We focus on mRNA processing, RNA modifications and their roles in development and disease.
-
Olivia Martinez
Johnson and Johnson Professor of Surgery
Current Research and Scholarly InterestsHost-Pathogen interactions; EBV B cell lymphomas; pathways of immune evasion in the growth and survival of EBV B cell lymphomas; mechanisms of graft rejection and tolerance induction; stem cell and solid organ transplantation.
-
Todd Martinez
David Mulvane Ehrsam and Edward Curtis Franklin Professor of Chemistry and Professor of Photon Science
On Leave from 10/01/2024 To 06/30/2025Current Research and Scholarly InterestsAb initio molecular dynamics, photochemistry, molecular design, mechanochemistry, graphical processing unit acceleration of electronic structure and molecular dynamics, automated reaction discovery, ultrafast (femtosecond and attosecond) chemical phenomena
-
Tarik F. Massoud, MD, PhD
Professor of Radiology (Neuroimaging and Neurointervention)
On Partial Leave from 08/12/2024 To 08/01/2025Current Research and Scholarly InterestsMy current interests are in molecular and translational imaging of the brain especially in neuro-oncology and cerebrovascular diseases, experimental aspects of neuroimaging, clinical neuroradiology, neuroradiological anatomy, and research education and academic training of radiologists and scientists.
-
Maya Mathur
Associate Professor (Research) of Pediatrics, of Medicine (Biomedical Informatics) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsSynthesizing evidence across studies while accounting for biases